Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies — Stella

Home/Influenza/

View on ClinicalTrials.gov

Recruiting

Back to Influenza trials

Trial locations(1 site)

United States

National Institutes of Health Clinical Center, Bethesda, Maryland

Key details

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Enrollment target

~1,000 participants

Started

October 2023

Primary completion

June 2026

Age range

18 Years – 65 Years

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.